GO:1900017 positive regulation of cytokine production involved in inflammatory response: Inflammatory Cytokine Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900017 describes any process that activates or increases the frequency, rate or extent of cytokine production specifically involved in inflammatory response.
• This term is a biological process node that sits downstream of pattern-recognition and cytokine receptor signaling and upstream of effector cytokine release.
• Key cytokines whose production is positively regulated include IL-17, IL-10, IL-21, TNF, IL-6 and IFN-gamma, depending on the cellular context.
• Dysregulated positive regulation of inflammatory cytokine production drives rheumatoid arthritis, Crohn's disease, acute lung injury and oral lichen planus.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the primary tools for causally testing genes that regulate this process.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to dissect GO:1900017 regulatory networks.
Description
GO:1900017, positive regulation of cytokine production involved in inflammatory response, is a Gene Ontology biological process term that captures any molecular event that activates or increases the frequency, rate or extent of cytokine production specifically tied to inflammation. Cytokines are small secreted proteins that coordinate immune cell recruitment, activation and resolution, and their production must be tightly controlled because excessive or prolonged output causes tissue damage. The term is therefore a central node linking innate and adaptive immune signaling to inflammatory pathology.
positive regulation of cytokine production involved in inflammatory response At A Glance
| GO ID | GO:1900017 |
|---|---|
| GO term | positive regulation of cytokine production involved in inflammatory response |
| Ontology | biological_process |
| Synonym | positive regulation of cytokine production involved in acute inflammatory response; up regulation of cytokine production involved in acute inflammatory response; up regulation of cytokine production involved in inflammatory response |
| Major function | Increases the frequency, rate or extent of cytokine production specifically involved in inflammatory response |
| Biological context | Innate and adaptive immune activation, host defense, inflammatory tissue injury |
| Representative cytokines | IL-17, IL-10, IL-21, TNF, IL-6, IFN-gamma |
| Representative regulators | TLR5, NF-kB, CPT1A, ELOVL7, IGF-like family member 2 |
| Disease relevance | Rheumatoid arthritis, Crohn's disease, acute lung injury, oral lichen planus, viral infection |
What Is GO:1900017?
In plain terms, GO:1900017 is the GO label for any process that turns up the production of cytokines that participate in inflammatory responses. It is a positive regulation term, meaning the regulator increases rather than decreases cytokine output, and it is restricted to cytokines whose production is involved in inflammatory response, excluding cytokine production in unrelated contexts. The QuickGO definition states: Any process that activates or increases the frequency, rate or extent of cytokine production involved in inflammatory response.
Why Is positive regulation of cytokine production involved in inflammatory response Important in Cell Biology?
GO:1900017 matters because the positive regulation of inflammatory cytokine production is the decisive step that converts a transient immune stimulus into a sustained inflammatory response. When this process is appropriately controlled it supports pathogen clearance and tissue repair, but when it is excessive or chronic it underlies autoimmune disease, inflammatory tissue damage and cytokine-driven pathology. Researchers studying infection, autoimmunity, cancer immunology and metabolic inflammation therefore need to identify which genes positively regulate this process and how they do so.
• Defines the regulatory step that amplifies cytokine output during inflammation.
• Controls the balance between protective immunity and immunopathology.
• Is a therapeutic target in rheumatoid arthritis and other autoimmune diseases.
• Is dysregulated in inflammatory bowel disease such as Crohn's disease.
• Contributes to acute lung injury through macrophage-derived cytokines.
• Drives T-cell-mediated tissue damage in oral lichen planus.
• Modulates antiviral immunity through IL-21 and related cytokines.
• Is influenced by macrophage lipid metabolism and ELOVL7 expression.
• Can be studied with CRISPR knockout, knock-in and overexpression cell models.
• Provides a mechanistic readout for NF-kB and TLR signaling studies.
What Happens During positive regulation of cytokine production involved in inflammatory response?
Recognition and receptor-proximal activation
In simple terms: Immune sensors detect danger signals and switch on the first signaling events.
The process begins when pattern-recognition receptors or cytokine receptors engage their ligands and activate proximal signaling. For example, TLR5 engagement by Roseburia intestinalis stimulates intestinal immunity and promotes cytokine production in a TLR5-dependent manner. In the central nervous system, neural-cell-intrinsic NF-kB signaling enhances reovirus virulence, showing that receptor-proximal NF-kB activation can positively regulate inflammatory cytokine output.
Transcriptional amplification of cytokine genes
In simple terms: Transcription factors turn up the reading of cytokine genes.
Activated transcription factors, notably NF-kB, drive increased transcription of cytokine genes. Neural-cell-intrinsic NF-kB signaling enhances reovirus virulence, consistent with NF-kB acting as a positive regulator of inflammatory cytokine production. In macrophages, increased ELOVL7 expression contributes to production of inflammatory cytokines in THP-1 cell-derived M1-like macrophages, linking lipid metabolic gene expression to transcriptional and post-transcriptional amplification of cytokine output.
Metabolic and phenotypic control of cytokine production
In simple terms: How a cell uses energy and lipids changes how many cytokines it makes.
Cellular metabolism and phenotype set the magnitude of cytokine production. CPT1A-IL-10-mediated macrophage metabolic and phenotypic alterations ameliorate acute lung injury, demonstrating that metabolic reprogramming of macrophages can modulate inflammatory cytokine production. Increased ELOVL7 expression contributes to production of inflammatory cytokines in THP-1 cell-derived M1-like macrophages, further supporting a role for lipid metabolism in this process.
T-cell cytokine networks and tissue-resident memory
In simple terms: T cells release cytokine cocktails that keep inflammation going.
T cells are major sources and regulators of inflammatory cytokines. CD8+ tissue-resident memory T cells induce oral lichen planus erosion via a cytokine network, showing that T-cell-derived cytokines positively regulate inflammatory tissue damage. Human CD4+ T cells regulate peripheral immune responses in rheumatoid arthritis via insulin-like growth factor-like family member 2, indicating that CD4+ T-cell products can positively regulate inflammatory cytokine production in autoimmune joints. IL-17 and IL-17-producing cells are central to protection versus pathology, and their cytokine output is a key node in this GO term.
Cytokine feedback and sustained inflammatory output
In simple terms: Cytokines can stimulate more cytokine production, creating a feedback loop.
Once produced, cytokines can act back on immune cells to further increase cytokine production. Interleukin-21 in viral infections illustrates how a single cytokine can shape the magnitude and duration of antiviral and inflammatory responses. IL-17 and IL-17-producing cells in protection versus pathology similarly show that cytokine feedback loops determine whether inflammation resolves or becomes pathological.
Key Genes Involved in GO:1900017 positive regulation of cytokine production involved in inflammatory response
The following genes and proteins have been experimentally linked to positive regulation of cytokine production involved in inflammatory response in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL17A | Pro-inflammatory cytokine produced by T cells and innate cells | Central to protection versus pathology in inflammatory disease |
| IL10 | Immunoregulatory cytokine that can modulate macrophage phenotype | CPT1A-IL-10 axis ameliorates acute lung injury |
| TLR5 | Pattern-recognition receptor that stimulates intestinal immunity | Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease |
| CD8A | Marker of cytotoxic and tissue-resident memory T cells | CD8+ tissue-resident memory T cells induce oral lichen planus erosion via cytokine network |
| CD4 | Marker of helper T cells that regulate peripheral immune responses | Human CD4+ T cells regulate rheumatoid arthritis via IGF-like family member 2 |
| IL21 | Cytokine that shapes antiviral and inflammatory responses | Interleukin-21 in viral infections |
| ELOVL7 | Fatty acid elongase involved in lipid metabolism | Increased expression contributes to inflammatory cytokine production in M1-like macrophages |
| CPT1A | Mitochondrial fatty acid oxidation enzyme | CPT1A-IL-10-mediated macrophage alterations ameliorate acute lung injury |
| NFKB1 | Transcription factor subunit driving inflammatory gene expression | Neural-cell-intrinsic NF-kB signaling enhances reovirus virulence |
| RELA | NF-kB transcription factor subunit | Neural-cell-intrinsic NF-kB signaling enhances reovirus virulence |
| IGFL2 | Insulin-like growth factor-like family member 2 | Human CD4+ T cells regulate rheumatoid arthritis via IGFL2 |
| TNF | Pro-inflammatory cytokine | Representative output of positive regulation of inflammatory cytokine production |
| IL6 | Pro-inflammatory cytokine | Representative output of positive regulation of inflammatory cytokine production |
| IFNG | Type II interferon with inflammatory functions | Representative output of T-cell cytokine networks |
| IL1B | Inflammasome-associated pro-inflammatory cytokine | Representative output of macrophage inflammatory cytokine production |
| CCL2 | Chemokine involved in monocyte recruitment | Representative inflammatory mediator downstream of cytokine networks |
| CXCL10 | Chemokine involved in T-cell recruitment | Representative inflammatory mediator downstream of cytokine networks |
How Is positive regulation of cytokine production involved in inflammatory response Regulated?
Positive regulation of cytokine production involved in inflammatory response is itself regulated at multiple levels. Receptor-proximal signaling through TLR5 and NF-kB provides one layer of control, as shown by TLR5-dependent intestinal immunity and neural-cell-intrinsic NF-kB signaling. Metabolic regulation provides another layer: CPT1A-IL-10-mediated macrophage metabolic and phenotypic alterations ameliorate acute lung injury, and increased ELOVL7 expression contributes to inflammatory cytokine production in M1-like macrophages. Cytokine feedback, including IL-21 and IL-17 loops, provides a third layer that can sustain or amplify inflammatory output.
positive regulation of cytokine production involved in inflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL17A | Inflammatory and autoimmune pathology | Knockout and overexpression T-cell models |
| IL10 | Acute lung injury | CPT1A-IL-10 macrophage knockout and knock-in models |
| TLR5 | Crohn's disease | TLR5 knockout intestinal epithelial and immune cell models |
| ELOVL7 | Macrophage-driven inflammation | ELOVL7 overexpression and knockout THP-1 macrophage models |
| NFKB1 | Viral virulence and neuroinflammation | Neural-cell NF-kB knockout and knock-in models |
Autoimmune and inflammatory arthritis
In rheumatoid arthritis, human CD4+ T cells regulate peripheral immune responses via insulin-like growth factor-like family member 2, linking T-cell cytokine regulation to joint inflammation. IL-17 and IL-17-producing cells are also central to protection versus pathology in inflammatory disease, and their positive regulation contributes to autoimmune tissue damage.
Inflammatory bowel disease
Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease, showing that microbial sensing can positively regulate cytokine production in the gut and that dysregulation of this process contributes to inflammatory bowel disease.
Acute lung injury and macrophage-driven inflammation
CPT1A-IL-10-mediated macrophage metabolic and phenotypic alterations ameliorate acute lung injury, demonstrating that macrophage cytokine production is a key driver of lung inflammatory injury and a target for modulation. Increased ELOVL7 expression contributes to production of inflammatory cytokines in THP-1 cell-derived M1-like macrophages, further linking macrophage metabolism to inflammatory cytokine output.
Mucosal and viral inflammatory disease
CD8+ tissue-resident memory T cells induce oral lichen planus erosion via a cytokine network, showing that T-cell cytokine production can directly cause mucosal tissue damage. Interleukin-21 in viral infections illustrates how cytokine production shapes antiviral immunity and inflammatory pathology. Neural-cell-intrinsic NF-kB signaling enhances reovirus virulence, connecting positive regulation of inflammatory cytokine production to viral disease severity.
From positive regulation of cytokine production involved in inflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for inflammatory cytokine production? | CRISPR knockout in macrophages or T cells |
| Does a specific point mutation alter cytokine regulatory activity? | CRISPR point-mutation knock-in cell line |
| Does a disease-associated variant increase cytokine output? | Knock-in of the variant into an immune cell line |
| Where and when is the regulator expressed during inflammation? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a metabolic gene increase cytokine production? | Doxycycline-inducible overexpression in THP-1 or primary macrophages |
| Which genes positively regulate this process at genome scale? | CRISPR library screening in cytokine reporter immune cells |
How to Study the positive regulation of cytokine production involved in inflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Secreted cytokine protein levels | Quantifying IL-17, IL-10, IL-21, TNF, IL-6 |
| Multiplex cytokine assay | Multiple secreted cytokines simultaneously | Profiling inflammatory supernatants from immune cells |
| RNA-seq | Transcriptome including cytokine genes | Identifying transcriptional regulators of cytokine production |
| Flow cytometry | Cytokine-producing cell frequency and phenotype | T-cell and macrophage cytokine networks |
| Intracellular cytokine staining | Cytokine protein within single cells | Defining T-cell subsets that produce inflammatory cytokines |
| CRISPR knockout | Loss-of-function effect on cytokine production | Testing requirement for candidate regulators |
| CRISPR knock-in | Effect of specific variants or tags | Modeling disease variants and tracking proteins |
| CRISPR library screening | Genome-scale regulators of cytokine output | Discovering new positive regulators of this process |
Cytokine profiling by ELISA and multiplex assays
Quantifying secreted cytokines such as IL-17, IL-10, IL-21, TNF and IL-6 is the direct readout for positive regulation of cytokine production involved in inflammatory response. Multiplex assays allow simultaneous measurement of multiple cytokines in supernatants from stimulated immune cells.
Transcriptional and RNA-seq analysis
RNA sequencing measures changes in cytokine gene transcription and identifies upstream regulators. This approach is useful for linking genes such as ELOVL7 or NF-kB subunits to increased cytokine gene expression in macrophages and neural cells.
Flow cytometry and intracellular cytokine staining
Flow cytometry identifies which cell types produce cytokines and how strongly. It is particularly valuable for studying T-cell subsets such as CD4+ and CD8+ tissue-resident memory T cells that drive cytokine networks in autoimmune and mucosal disease.
CRISPR-based perturbation and reporter assays
CRISPR knockout, knock-in and overexpression combined with cytokine reporter cell lines allow causal testing of candidate regulators. These methods connect specific genes to the positive regulation of inflammatory cytokine production.
How CRISPR Can Be Used to Study GO:1900017 positive regulation of cytokine production involved in inflammatory response
Knockout
CRISPR knockout is used to delete candidate genes such as CPT1A, ELOVL7 or TLR5 and measure the effect on inflammatory cytokine production. For example, CPT1A-IL-10-mediated macrophage metabolic and phenotypic alterations ameliorate acute lung injury, and Roseburia intestinalis stimulates TLR5-dependent intestinal immunity, both of which can be dissected with knockout models.
Point Mutation
CRISPR point mutation introduces specific nucleotide changes to test whether a particular residue or regulatory element is required for positive regulation of cytokine production. This is useful for dissecting signaling domains in NF-kB pathway components and for modeling disease-associated variants.
Knock-in
CRISPR knock-in can insert disease-associated variants, reporter cassettes or epitope tags at endogenous loci. Tagged knock-in allows tracking of cytokine regulators in primary immune cells, while variant knock-in tests whether a specific allele increases inflammatory cytokine output.
Overexpression
CRISPR overexpression or inducible overexpression is used to test whether increasing a gene such as ELOVL7 is sufficient to increase inflammatory cytokine production. Increased expression of ELOVL7 contributes to production of inflammatory cytokines in THP-1 cell-derived M1-like macrophages, making overexpression a direct test of sufficiency.
How EDITGENE Supports positive regulation of cytokine production involved in inflammatory response Research
Researchers studying positive regulation of cytokine production involved in inflammatory response-related genes often need to determine whether a candidate gene is causally involved in increasing cytokine output, and at what step of the inflammatory response it acts. EDITGENE provides publication-ready CRISPR cell models and screening services to answer these questions with rigor.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cytokine production involved in inflammatory response research.
Frequently Asked Questions About positive regulation of cytokine production involved in inflammatory response
What is GO:1900017?
GO:1900017 is the Gene Ontology biological process term for positive regulation of cytokine production involved in inflammatory response, meaning any process that activates or increases the frequency, rate or extent of cytokine production specifically involved in inflammation.
What genes are involved in positive regulation of cytokine production involved in inflammatory response?
Genes experimentally linked to this process include IL17A, IL10, TLR5, CD8A, CD4, IL21, ELOVL7, CPT1A, NFKB1, RELA and IGFL2, based on studies of inflammatory and autoimmune disease.
Which cytokines are positively regulated in inflammatory response?
Representative cytokines include IL-17, IL-10, IL-21, TNF, IL-6 and IFN-gamma, depending on the cell type and disease context.
How is GO:1900017 studied experimentally?
It is studied by measuring secreted and intracellular cytokines with ELISA, multiplex assays and flow cytometry, combined with CRISPR knockout, knock-in and overexpression to test causality.
What diseases are linked to dysregulated inflammatory cytokine production?
Rheumatoid arthritis, Crohn's disease, acute lung injury, oral lichen planus and severe viral infection have all been linked to altered positive regulation of inflammatory cytokine production.
What is the role of NF-kB in this process?
NF-kB signaling acts as a positive regulator of inflammatory cytokine production, as shown by neural-cell-intrinsic NF-kB signaling enhancing reovirus virulence.
How does metabolism affect inflammatory cytokine production?
Macrophage metabolic state influences cytokine output, as shown by CPT1A-IL-10-mediated metabolic and phenotypic alterations ameliorating acute lung injury and by ELOVL7 contributing to inflammatory cytokine production in M1-like macrophages.
Can CRISPR be used to study GO:1900017?
Yes, CRISPR knockout, point mutation, knock-in and overexpression are widely used to test whether specific genes positively regulate inflammatory cytokine production.
What is the difference between GO:1900017 and general cytokine production?
GO:1900017 is restricted to cytokine production involved in inflammatory response, so it excludes cytokine production in non-inflammatory contexts and specifically covers positive regulation of the inflammatory cytokine output.
Why is positive regulation of inflammatory cytokine production important therapeutically?
Because excessive or chronic inflammatory cytokine production drives autoimmune and inflammatory tissue damage, identifying positive regulators provides candidate targets for therapeutic intervention.
Conclusion
GO:1900017, positive regulation of cytokine production involved in inflammatory response, is a central biological process node that connects immune sensing, transcriptional amplification, metabolic state and cytokine feedback to inflammatory output. Experimental evidence from rheumatoid arthritis, Crohn's disease, acute lung injury, oral lichen planus and viral infection shows that this process is both protective and pathogenic depending on context. CRISPR-based cell models and screening are the most direct way to identify and validate the genes that positively regulate this process.
References
- 1. Mills KHG. 2023. IL-17 and IL-17-producing cells in protection versus pathology.. Nat Rev Immunol 23(1):38-54 PMID: 35790881
- 2. Wang M et al.. 2024. CPT1A-IL-10-mediated macrophage metabolic and phenotypic alterations ameliorate acute lung injury.. Clin Transl Med 14(8):e1785 PMID: 39090662
- 3. Shen Z et al.. 2022. Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease.. EBioMedicine 85:104285 PMID: 36182776
- 4. Qing M et al.. 2023. CD8(+) tissue-resident memory T cells induce oral lichen planus erosion via cytokine network.. Elife 12 PMID: 37555396
- 5. Murakami A et al.. 2025. Human CD4(+) T cells regulate peripheral immune responses in rheumatoid arthritis via insulin-like growth factor-like family member 2.. Sci Immunol 10(110):eadr3838 PMID: 40749037
- 6. Asao H. 2021. Interleukin-21 in Viral Infections.. Int J Mol Sci 22(17) PMID: 34502427
- 7. Inoue Y et al.. 2023. Increased expression of ELOVL7 contributes to production of inflammatory cytokines in THP-1 cell-derived M1-like macrophages.. J Clin Biochem Nutr 72(3):215-224 PMID: 37251958
- 8. Taylor GM et al.. 2023. Neural-Cell-Intrinsic NF-κB Signaling Enhances Reovirus Virulence.. J Virol 97(1):e0144222 PMID: 36541803
